2 results match your criteria: "Baylor College of Medicine and Texas Children's Cancer and Hematology Centers[Affiliation]"
Allowing Adolescents to Weigh Benefits and Burdens of High-stakes Therapies.
Pediatrics
July 2019
Section of Hematology-Oncology, Department of Pediatrics, Center for Medical Ethics and Health Policy, Baylor College of Medicine and Texas Children's Cancer and Hematology Centers, Houston, Texas.
We present the case of a girl aged 17 years and 10 months who has a strong family history of long QT syndrome and genetic testing confirming the diagnosis of long QT syndrome in the patient also. She was initially medically treated with β-blocker therapy; however, after suffering 1 episode of syncope during exertion, she underwent placement of an implantable cardioverter defibrillator. Since then, she has never had syncope.
View Article and Find Full Text PDFStandardized high-sensitivity flow cytometry testing for paroxysmal nocturnal hemoglobinuria in children with acquired bone marrow failure disorders: A single center US study.
Cytometry B Clin Cytom
July 2018
Pathology and Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
Background: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hematopoietic stem cell disorder that has not been well-documented in children, particularly those with acquired bone marrow failure disorders (ABMFD)-acquired aplastic anemia (AAA) and myelodysplastic syndrome (MDS). Therefore, we sought to determine the prevalence of PNH populations in children with ABMFD.
Methods: PNH testing was performed in children with an ABMFD diagnosis using high sensitivity (≥0.